VBI Assistant Professor Iuliana Lazar, along with VBI Professor Ina Hoeschele and VBI postdoctoral fellow Jenny Armenta, developed the method*, which uses proteomic technologies the fast biomarker fingerprinting in complex cellular extracts. The goal of biomarkers and screening for changes in the levels of key proteins in the cell in response to the occurrence or development of a disease to be identified synmcg.com synmcg.com . Such research promises to the capabilities of such techniques for the early detection of cancer, which could significantly reduce the mortality rate of advance illnesses such as cancer.
Notes:. Ovarian cancer affects about one in 70 Canadian women. Approximately 2500 every year and the every year and the five-year survival rate is only 30 %. This study was VGH VGH & UBC Hospital Foundation and the BC Cancer Foundation, and Genome BC for the development of Illumina sequencing at the BC Cancer Agency Genome Sciences Centre. OvCaRe and the BC Cancer Agency Genome Sciences Centre the the Michael Smith Foundation for Health Research. Ovarian Cancer Research Program is a multidisciplinary research program with clinicians and researchers in gynecology, pathology, medical oncology. OvCaRe is a unique collaboration between the BC Cancer Agency , Vancouver Coastal Health Research Institute and the University of British Columbia. Funding is provided through donations to VGH & UBC Hospital Foundation and the BC Cancer Foundation, in a joint partnership created a campaign to raise funds to OvCaRe possible provided. The OvCaRe team is considered a leader in ovarian cancer research, new approaches to better identify, Understanding and treating this disease.
After prion injection into the brain and motoneuron system of monitored Ermolayev and colleagues described in the clinical features. In If clinical symptoms occurred, researchers found a significantly reduced axonal transport in the neurons of from two center of the brain, of the red nucleus and the motor cortex. E.xonal transport impairments were seen at 45 % of the nerve cells red core and up to 94 % of the motor cortex neurons. – ‘The results are will find find better opportunities for diagnose and treat prion diseases,’said Dr. Vladimir Ermolayev.